NCT05093023View on ClinicalTrials.gov

ABCB1 SNPs as Predictors of PIPN

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 31, 2020

Conditions
Paclitaxel Adverse ReactionNeuropathy;PeripheralBreast Cancer
Interventions
GENETIC

Real-Time PCR

Genomic DNA was extracted from 2 ml of venous blood. ABCB1 1236 G\>A and 3435 G\>A were genotyped using predesigned TaqMan SNP genotyping assays on a stepOne PCR instrument in accordance with the manufacturer's protocol.

Trial Locations (1)

Unknown

Nasser's Institute Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05093023 - ABCB1 SNPs as Predictors of PIPN | Biotech Hunter | Biotech Hunter